Recognizing The Month Of April 2023 As "parkinson's Disease Awareness Month" In The State Of The Delaware.
The resolution underscores that approximately 2,500 Delaware residents are diagnosed with Parkinson's disease, complemented by statistics indicating a global prevalence surpassing 10 million. The economic implications are notable, as the cost of managing PD in the U.S. is estimated to be nearly $52 billion annually, projected to increase significantly in the coming years. This recognition serves as a catalyst for conversations about medical resources, policy-making, and community support systems that can enhance the quality of life for those affected by PD.
SCR26, also known as Senate Concurrent Resolution No. 26, recognizes April 2023 as 'Parkinson's Disease Awareness Month' in the State of Delaware. This resolution aims to raise awareness about Parkinson's disease (PD), which is described as a chronic and progressive condition affecting the nervous system. The bill draws attention to the significant impact PD has not only on individuals suffering from the disease but also on society, highlighting that it is the second most common neurodegenerative disease in the United States, with a rising number of diagnoses and substantial economic costs associated with treatment and care.
General sentiment towards this resolution is largely positive, marked by an acknowledgment of the need for more focus on Parkinson's disease and better public understanding. This initiative garners support from a cross-section of legislators and the community, as it serves to highlight the importance of awareness and advocacy efforts in addressing chronic illnesses. The theme #Take6forPD promotes individual engagement and encourages the public to devote time to learning about the condition and its ramifications.
While SCR26 champions awareness and education regarding Parkinson's disease, it may also open discussions about healthcare access and the need for increased funding for research and treatment options. There could be points of contention regarding the adequacy of state resources to support those with PD, the efficacy of public awareness campaigns, and how best to influence policy to support community health initiatives. However, the primary focus of SCR26 remains on recognition and advocacy.